NEUROONE MEDICAL TECHNOLOGIES Corp Annual Cost of Revenue in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Cost of Revenue history and growth rate from 2021 to 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Cost of Revenue for the quarter ending June 30, 2024 was $544K, a 40.8% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Cost of Revenue for the twelve months ending June 30, 2024 was $2.79M, a 170% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Cost of Revenue for 2023 was $1.5M, a 518% increase from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Cost of Revenue for 2022 was $242K, a 12.3% decline from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.5M +$1.25M +518% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-15
2022 $242K -$33.9K -12.3% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-15
2021 $276K Oct 1, 2020 Sep 30, 2021 10-K 2022-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.